felbamate

Generic: felbamate

Labeler: zydus lifesciences limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name felbamate
Generic Name felbamate
Labeler zydus lifesciences limited
Dosage Form TABLET
Routes
ORAL
Active Ingredients

felbamate 400 mg/1

Manufacturer
Zydus Lifesciences Limited

Identifiers & Regulatory

Product NDC 70771-1077
Product ID 70771-1077_785f1747-e29d-432a-82e7-fcaeea202327
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208970
Listing Expiration 2026-12-31
Marketing Start 2017-08-15

Pharmacologic Class

Established (EPC)
anti-epileptic agent [epc]
Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 707711077
Hyphenated Format 70771-1077

Supplemental Identifiers

RxCUI
198358 198359
UNII
X72RBB02N8
NUI
N0000175753 N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name felbamate (source: ndc)
Generic Name felbamate (source: ndc)
Application Number ANDA208970 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 400 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (70771-1077-1)
  • 30 TABLET in 1 BOTTLE (70771-1077-3)
  • 10 BLISTER PACK in 1 CARTON (70771-1077-4) / 10 TABLET in 1 BLISTER PACK
  • 500 TABLET in 1 BOTTLE (70771-1077-5)
  • 90 TABLET in 1 BOTTLE (70771-1077-9)
source: ndc

Packages (5)

Ingredients (1)

felbamate (400 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "785f1747-e29d-432a-82e7-fcaeea202327", "openfda": {"nui": ["N0000175753", "N0000008486"], "unii": ["X72RBB02N8"], "rxcui": ["198358", "198359"], "spl_set_id": ["efa55cb2-b625-4392-9ddb-0a8ad8ee58c4"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (70771-1077-1)", "package_ndc": "70771-1077-1", "marketing_start_date": "20170815"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (70771-1077-3)", "package_ndc": "70771-1077-3", "marketing_start_date": "20170815"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (70771-1077-4)  / 10 TABLET in 1 BLISTER PACK", "package_ndc": "70771-1077-4", "marketing_start_date": "20170815"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (70771-1077-5)", "package_ndc": "70771-1077-5", "marketing_start_date": "20170815"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (70771-1077-9)", "package_ndc": "70771-1077-9", "marketing_start_date": "20170815"}], "brand_name": "Felbamate", "product_id": "70771-1077_785f1747-e29d-432a-82e7-fcaeea202327", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "70771-1077", "generic_name": "Felbamate", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Felbamate", "active_ingredients": [{"name": "FELBAMATE", "strength": "400 mg/1"}], "application_number": "ANDA208970", "marketing_category": "ANDA", "marketing_start_date": "20170815", "listing_expiration_date": "20261231"}